David Altshuler, EVP, Chief Scientific Officer: Vertex Pharmaceuticals VRTX Sell · Filed 25/02/24

Trade details

Type: Insider sale
Amount: $533,280
Shares · price: 1,111 sh · $480.00 a share
Held after: 45,019 sh
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Chief Scientific Officer
Trade date: 25/02/20
Filed: 25/02/24
Days to filing: 4 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/21~25/03/22

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/17
Traded 25/03/13
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/13
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10